• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例复发性急性胰腺炎合并危及生命的非典型溶血尿毒综合征的病例报告。

A case report of recurrent acute pancreatitis associated with life threatening atypical hemolytic uremic syndrome.

作者信息

Jean-Marie Elizabeth M, Cho Jonathan J, Trevino Jose G

机构信息

Department of Surgery, University of Florida Health Sciences Center.

Department of Anatomy and Cell Biology, College of Medicine, University of Florida, Gainesville, FL, United States.

出版信息

Medicine (Baltimore). 2020 May 29;99(22):e19731. doi: 10.1097/MD.0000000000019731.

DOI:10.1097/MD.0000000000019731
PMID:32481360
Abstract

INTRODUCTION

Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy defined by the sudden onset of hemolytic anemia, thrombocytopenia, and acute kidney injury (AKI). HUS is categorized as either typical, caused by Shiga toxin-producing Escherichia coli infection, or atypical HUS (aHUS), usually complement mediated or secondary to systemic disease. We describe a rare case of aHUS in an adult male patient with recurrent acute pancreatitis.

PATIENT CLINICAL FINDINGS

A 32-year-old Caucasian male presented to our institution for his third episode of alcohol-induced pancreatitis. He presented with abdominal pain, elevated lipase and pancreatic inflammation on computed tomography consistent with acute pancreatitis. While admitted, he developed sudden onset severe thrombocytopenia, AKI and hemolytic anemia.

DIAGNOSIS, THERAPEUTIC INTERVENTIONS, OUTCOMES: Peripheral blood smear, haptoglobin and hemoglobin level confirmed microangiopathic hemolytic anemia. Worsening anemia, thrombocytopenia and AKI were consistent with the diagnosis of aHUS. The patient's pancreatitis resolved with supportive measures, but resolution of significant thrombocytopenia and AKI was not achieved until administration of eculizumab, a complement inhibiting therapy. Eculizumab therapy provided dramatic improvement in this patient, with platelet count increasing from a low of 11,000 to >100,000 within 48 hours of therapy. Creatinine and hemoglobin levels returned to baseline within 3 weeks.

CONCLUSION

Recurrent pancreatitis is suggested as the etiology of atypical HUS in this patient and this condition should be recognized and treated in a timely manner for optimal clinical outcomes.

摘要

引言

溶血尿毒综合征(HUS)是一种血栓性微血管病,其特征为溶血性贫血、血小板减少和急性肾损伤(AKI)突然发作。HUS分为典型型,由产志贺毒素大肠杆菌感染引起,或非典型HUS(aHUS),通常由补体介导或继发于全身性疾病。我们描述了一例成年男性患者罕见的aHUS病例,该患者患有复发性急性胰腺炎。

患者临床发现

一名32岁的白种男性因酒精性胰腺炎第三次发作前来我院就诊。他表现为腹痛、脂肪酶升高以及计算机断层扫描显示的胰腺炎症,符合急性胰腺炎表现。住院期间,他突然出现严重血小板减少、AKI和溶血性贫血。

诊断、治疗干预及结果:外周血涂片、触珠蛋白和血红蛋白水平证实为微血管病性溶血性贫血。贫血、血小板减少和AKI的加重与aHUS的诊断相符。患者的胰腺炎通过支持治疗得以缓解,但直到给予依库珠单抗(一种补体抑制疗法)后,严重血小板减少和AKI才得到缓解。依库珠单抗治疗使该患者病情显著改善,治疗后48小时内血小板计数从低至11,000升至>100,000。肌酐和血红蛋白水平在3周内恢复至基线。

结论

复发性胰腺炎被认为是该患者非典型HUS的病因,应及时识别并治疗这种情况以获得最佳临床结果。

相似文献

1
A case report of recurrent acute pancreatitis associated with life threatening atypical hemolytic uremic syndrome.一例复发性急性胰腺炎合并危及生命的非典型溶血尿毒综合征的病例报告。
Medicine (Baltimore). 2020 May 29;99(22):e19731. doi: 10.1097/MD.0000000000019731.
2
Genetic Atypical Hemolytic-Uremic Syndrome遗传性非典型溶血性尿毒症综合征
3
Use of complement C5-inhibitor eculizumab in patients with infection-associated hemolytic uremic syndrome - a case-series report.补体C5抑制剂依库珠单抗在感染相关性溶血尿毒综合征患者中的应用——病例系列报告
BMC Pediatr. 2025 Mar 11;25(1):181. doi: 10.1186/s12887-025-05546-3.
4
Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review.产志贺毒素大肠埃希菌溶血尿毒综合征应用依库珠单抗治疗:系统评价。
Pediatr Nephrol. 2024 May;39(5):1369-1385. doi: 10.1007/s00467-023-06216-1. Epub 2023 Dec 6.
5
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.预防腹泻相关性溶血尿毒综合征的干预措施。
Cochrane Database Syst Rev. 2025 Apr 25;4(4):CD012997. doi: 10.1002/14651858.CD012997.pub3.
6
Perioperative Management of Atypical Hemolytic Uremic Syndrome in a Patient on Maintenance Eculizumab Therapy: A Case Report and Review of the Literature.接受依库珠单抗维持治疗患者的非典型溶血性尿毒症综合征围手术期管理:病例报告及文献综述
Nephron. 2025;149(9):539-544. doi: 10.1159/000546526. Epub 2025 May 23.
7
INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome.INM004:抗志贺毒素多克隆中和抗体作为溶血尿毒综合征的一种治疗方法。
Toxins (Basel). 2025 Jun 5;17(6):282. doi: 10.3390/toxins17060282.
8
Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.依库珠单抗在系统性红斑狼疮伴血栓性微血管病及 CFHR1-CFHR3 杂合缺失患者中的应用:病例报告及系统评价。
Clin Rheumatol. 2017 Dec;36(12):2859-2867. doi: 10.1007/s10067-017-3823-2. Epub 2017 Sep 13.
9
The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review.依库珠单抗治疗儿童非典型溶血性尿毒症综合征的系统评价
Pediatr Nephrol. 2023 Jan;38(1):61-75. doi: 10.1007/s00467-022-05683-2. Epub 2022 Jul 21.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Disorder of intracellular cobalamin metabolism: Importance of rapid diagnostic illustrated by a case report of early-onset methylmalonic aciduria and homocystinuria, cobalamin C type.细胞内钴胺素代谢紊乱:以早发型甲基丙二酸尿症和同型胱氨酸尿症(钴胺素C型)病例报告说明快速诊断的重要性。
Heliyon. 2025 Jan 23;11(3):e42086. doi: 10.1016/j.heliyon.2025.e42086. eCollection 2025 Feb 15.
2
Atypical Hemolytic Uremic Syndrome Secondary to Pancreatitis: A Case Report.胰腺炎继发非典型溶血性尿毒症综合征:一例报告
Cureus. 2023 Feb 24;15(2):e35434. doi: 10.7759/cureus.35434. eCollection 2023 Feb.
3
Characteristics and genetic analysis of patients suspected with early-onset systemic lupus erythematosus.

本文引用的文献

1
Atypical haemolytic uremic syndrome secondary to acute pancreatitis: a unique presentation.急性胰腺炎继发非典型溶血尿毒综合征:一种独特的表现。
BMJ Case Rep. 2019 Sep 12;12(9):e230822. doi: 10.1136/bcr-2019-230822.
2
Hemolytic-uremic Syndrome Complicating Acute Pancreatitis.溶血尿毒综合征并发急性胰腺炎
Indian J Crit Care Med. 2017 Aug;21(8):534-536. doi: 10.4103/ijccm.IJCCM_121_17.
3
A rare case of thrombotic microangiopathy triggered by acute pancreatitis.一例由急性胰腺炎引发的血栓性微血管病罕见病例。
疑似早发性系统性红斑狼疮患者的特征和基因分析。
Pediatr Rheumatol Online J. 2022 Aug 13;20(1):68. doi: 10.1186/s12969-022-00722-6.
BMJ Case Rep. 2017 May 15;2017:bcr-2016-218581. doi: 10.1136/bcr-2016-218581.
4
Complement in Pancreatic Disease-Perpetrator or Savior?补体在胰腺疾病中——是加害者还是拯救者?
Front Immunol. 2017 Jan 17;8:15. doi: 10.3389/fimmu.2017.00015. eCollection 2017.
5
An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab.一例在内镜逆行胰胆管造影术后发生溶血性尿毒症综合征的罕见病例,使用依库珠单抗后迅速好转。
Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):257-61.
6
Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.伴有cblC缺陷患者的肾血栓性微血管病:对一个未被充分认识的疾病实体的综述
Pediatr Nephrol. 2017 May;32(5):733-741. doi: 10.1007/s00467-016-3399-0. Epub 2016 Jun 11.
7
Syndromes of thrombotic microangiopathy.血栓性微血管病的综合征。
N Engl J Med. 2014 Aug 14;371(7):654-66. doi: 10.1056/NEJMra1312353.
8
Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency.成人起病型依库珠单抗耐药性溶血尿毒症综合征伴钴胺素 C 缺乏。
Am J Kidney Dis. 2014 Jan;63(1):119-23. doi: 10.1053/j.ajkd.2013.08.031. Epub 2013 Nov 6.
9
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.依库珠单抗治疗非典型溶血尿毒综合征。
N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981.
10
Thrombotic microangiopathy as a complication of recurrent pancreatitis.血栓性微血管病作为复发性胰腺炎的一种并发症。
Indian J Nephrol. 2011 Jul;21(3):215-7. doi: 10.4103/0971-4065.78073.